Appropriate Information Disclosure and Information Management

Appropriate Information Disclosure

Sumitomo Dainippon Pharma recognizes the importance of transparency in earning the trust of society, and as such, strives to disclose corporate information in a timely, appropriate and fair manner to its stakeholders.

We undertake disclosure of information under due recognition of Japan's Financial Instruments and Exchange Act, the Timely Disclosure Rules of the Tokyo Stock Exchange (TSE), our in-house regulations for management and disclosure of information, and other rules.

Information that requires timely disclosure, such as the Company's financial results, is promptly disclosed through the Timely Disclosure Network (TDnet) system of the Tokyo Stock Exchange and also published on our corporate website.

We also actively disclose information not requiring timely disclosure, including corporation information and product information, through news releases to media outlets and our own corporate website.

For medical professionals as well as patients and their families, Sumitomo Dainippon Pharma provides information in Japanese on various diseases through its Medical Information Website and Sumitomo Dainippon Pharma's Health Information Website (Japanese only), which are linked to its corporate website, and other media such as television monitors installed in hospitals and clinics.

Information Management

"Information" is an essential asset in our corporate activities, and how it is utilized and protected is of particular importance to Sumitomo Dainippon Pharma. We have settled global policies for records and information management as well as various rules for information management and IT security to minimize risks.

Management for confidential information

In accordance with the internal rules, we manage confidential information in an appropriate manner according to the degree of importance. We have the information management system such as executive officer who is in charge of information management and the Information Management Committee. In order to prevent insider trading, we have internal rules which provides, among others, the basic matters complied by all officers and employees and we educate them concerning those rules.

Information Security

With respect to our efforts toward information security, we continue to update technical measures, rules and procedures according to change of social environment or progress of information technology. We also strive to work for strengthening information security in our group companies.

In addition, we focus on education with the aim that officers and employees strongly recognize the importance of information security and ensure full compliance with rules and regulations. Moreover, we provide them with information security training periodically to keep awareness about information security high.

Managing Personal Information

Sumitomo Dainippon Pharma has a privacy policy in place, and in accordance with its internal rules, properly handles and protects personal information acquired through its business activities from medical professionals, product users, business partners, shareholders, employees and other persons. In addition, Sumitomo Dainippon Pharma works for actively promoting protection of personal information such as building a solid management system that includes an executive officer in charge of personal information management and a personal information hotline, and educating and training its officers and employees.